UBS Group
SBCWW

UBS Group’s SBC Medical Group Warrants SBCWW Stock Holding History

UBS Group’s Portfolio SBCWW Stock Details SBCWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,601
Closed -$484 – 11033
2025
Q1 		$484 Buy
2,601
+2,201
+550% +$530 ﹤0.01% 9764
2024
Q4 		$96 Buy
+400
New +$97 ﹤0.01% 9658

Other funds holding SBCWW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group's SBCWW Position: Q2 2025 in Review

UBS Group sold out of SBC Medical Group Warrants (SBCWW) in Q2 2025, closing a stake of 2,601 shares — an estimated $484 sold.

UBS Group first reported a position in SBCWW in Q4 2024 and held it in 2 quarters. The position peaked at $484 in Q1 2025. 18 funds tracked by Wall St. Rank hold SBCWW as of Q2 2025.

  • UBS Group reported no remaining SBC Medical Group Warrants position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 2,601 SBC Medical Group Warrants shares in Q2 2025, an estimated $484.
  • UBS Group first reported a position in SBC Medical Group Warrants in Q4 2024 and held it in 2 quarters.
  • UBS Group's SBC Medical Group Warrants position peaked at $484 in Q1 2025.
  • 18 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.